Table 4.
Initial treatment | TACE session frequency | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
None | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | Median no. (range) | |
Resection (n = 202) | 73 | 37 | 25 | 26 | 11 | 14 | 3 | 4 | 2 | 3 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 (1–14) |
RFA/PEI (n = 31) | 10 | 10 | 3 | 3 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 (1–9) |
TACE (n = 977) | 283 | 181 | 136 | 101 | 69 | 53 | 50 | 27 | 24 | 16 | 14 | 9 | 6 | 3 | 4 | 0 | 0 | 0 | 0 | 1 | 3 (1–19) |
EBRT (n = 65) | 36 | 12 | 5 | 6 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 (1–8) |
Chemotherapy (n = 72) | 58 | 6 | 3 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 (1–10) |
Total (n = 1357) | 464 | 250 | 173 | 138 | 85 | 70 | 55 | 31 | 29 | 20 | 16 | 10 | 7 | 3 | 5 | 0 | 0 | 0 | 0 | 1 | 3 (1–19) |
RPRTs recurring, progressing, or remaining tumors, RFA radiation frequency ablation, PEI percutaneous ethanol injection, TACE transarterial chemoembolization, EBRT external beam radiation therapy